Inventor · disambiguated record
Xiaochuan Cai
Also filed as: CAI XIAOCHUAN
5 granted patents·11 pending applications·5 citations·filing 2016–2024
68Inventor score
Files withSANEGENE BIO USA INC10MEMORIAL SLOAN KETTERING CANCER CENTER4DICERNA PHARMACEUTICALS INC1SHENZHEN INST ADV TECH1
Top patents by PatentIndex Score
16 records- 0189US11453696B2Adenosine analogs as methyltransferase inhibitors for treating cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Sep 27, 2022·2 cites·20 claims
- 0286US10730903B2Adenosine analogs as methyltransferase inhibitors for treating cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Aug 4, 2020·3 cites·20 claims
- 0373US12043645B2Adenosine analogs as methyltransferase inhibitors for treating cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Jul 23, 2024·0 cites·20 claims
- 0469US2025059540A1Double stranded rna targeting angiopoietin-like 3 (angptl-3) and methods of use thereofSANEGENE BIO USA INC·Filed 2024·Application pending·0 cites
- 0563US12465647B21′-alkyl modified ribose derivatives and methods of useSANEGENE BIO USA INC·Filed 2022·Granted Nov 11, 2025·0 cites·25 claims
- 0662US2023159930A1Double stranded rna targeting angiopoietin-like 3 (angptl-3) and methods of use thereofSANEGENE BIO USA INC·Filed 2022·Application pending·0 cites
- 0759US2024218363A1Optimized 2'- modified ribose derivatives and methods of useSANEGENE BIO USA INC·Filed 2023·Application pending·0 cites
- 0859US2025064939A1Lipid-based enhancement agent for rna delivery and therapySANEGENE BIO USA INC·Filed 2024·Application pending·0 cites
- 0958US2025018045A1Lipid-based conjugates for systemic, central nervous system, peripheral nervous system, and ocular deliverySANEGENE BIO USA INC·Filed 2024·Application pending·0 cites
- 1058US2024002857A1Double stranded rna targeting 17-beta hydroxysteroiddehydrogenase 13 (hsd17b13) and methods of use thereofSANEGENE BIO USA INC·Filed 2023·Application pending·0 cites
- 1156US12223626B2Method for denoising image, apparatus, and computer-readable storage mediumSHENZHEN INST ADV TECH·Filed 2022·Granted Feb 11, 2025·0 cites·20 claims
- 1255US2023277675A1Systemic delivery of oligonucleotidesDICERNA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1354US2023227480A1Polyhydroxylated cyclopentane derivatives and methods of useSANEGENE BIO USA INC·Filed 2022·Application pending·0 cites
- 1454US2023346819A15'-modified carbocyclic ribonucleotide derivatives and methods of useSANEGENE BIO USA INC·Filed 2023·Application pending·0 cites
- 1551US2023241224A12'-alkyl or 3'- alkyl modified ribose derivatives and methods of useSANEGENE BIO USA INC·Filed 2022·Application pending·0 cites
- 1635US2018305391A1Cofactor analogs as methyltransferase inhibitors for treating cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaochuan Cai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →